Jayateerth S. Bhavikatti, CSIR-National Chemical Laboratory, Pune, India
There have been so many things discovered till date in this universe, nevertheless, there are too many discoveries to happen. Cheers to the discoverers! They spend their life helping people. Here is one such discovery. So far, three pairs of salivary glands were studied in humans. Researches who work at the Netherlands Cancer Institute discovered two more salivary glands behind the nasopharynx, in humans. This was discovered in all 100 people considered in a test to investigate the side effects on radiation on the head and neck. The researchers along with their colleagues at the Amsterdam UMC, name these as tubarial glands.
Vogel, a radiation therapist, explains – “Radiation therapies can damage the salivary glands and patients may have to suffer from trouble while eating, speaking, and swallowing”. The possibilities of such complications were reported in the collaborative research by the Netherlands Cancer Institute and University Medical Centre Groningen (UMCG) after analysing the data from 723 patients who underwent radiation treatment. They concluded that it is important to avoid these areas while using radiation as a treatment for tumours in the neck and head regions. Discovery of these glands paved way for advances in a healthier radiation therapy overall.
Many such things happen in our laboratories too, but get neglected due to ignorance. If we keep our eyes open, we would understand our world better.
Also read: Is it possible to detect COVID 19 under 15 minutes?
Reference: https://www.nki.nl/topmenu/about-the-nki/news/cancer-researchers-discover-new-salivary-gland/
- The Corrosion Prediction from the Corrosion Product Performance
- Nitrogen Resilience in Waterlogged Soybean plants
- Cell Senescence in Type II Diabetes: Therapeutic Potential
- Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
- AI Literacy in Early Childhood Education: Challenges and Opportunities
Gene Expression Profiling to detect Survival Prediction of Diffuse Large B-Cell Lymphoma
Shreelekha Pore, National Institute of Technology, Rourkela 25% of non-Hodgkin Lymphoma includes Diffuse Large B-Cell Lymphoma (DLBCL). Through the study of cell-of-origin (COO) using gene expression profiling (GEP), DLBCL has been classified as- germinal centre B-cell-like and activated B-cell-like. Artificial intelligence is widely used for prognostic purposes for certain diseases. Machine Learning can be used […]